Aura Biosciences, Inc. (AURA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -29.89M | -20.47M | -20.14M | -20.77M | -23.36M | -23.95M | -15.27M | -16.13M | -24.45M | -17.39M | -15.4M | -14.64M | -16.41M | -18.01M | -10.76M | -10.63M | -15.2M | -12.09M | -8.69M | -6.5M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -27.99% | 14.54% | -31.89% | -28.81% | 4.49% | -37.76% | 0.84% | -10.13% | -48.99% | 3.48% | -43.15% | -37.8% | -7.97% | -49.04% | -23.82% | -63.58% | -195.89% | -221.69% | - | - |
| Net Income | -33.69M | -25.56M | -26.13M | -27.02M | -27.48M | -25.83M | -21.04M | -20.34M | -19.71M | -22.13M | -18.51M | -18.3M | -17.47M | -16.56M | -15.9M | -13.47M | -12.84M | -11.63M | -8.84M | -8.85M |
| Depreciation & Amortization | 274K | 272K | 280K | 286K | 291K | 291K | 313K | 313K | 306K | 324K | 343K | 300K | 328K | 323K | 302K | 296K | 256K | 230K | 218K | 200K |
| Stock-Based Compensation | 0 | 3.28M | 3.69M | 3.83M | 3.51M | 2.94M | 2.75M | 3.13M | 2.91M | 2.6M | 2.33M | 0 | 1.91M | 1.81M | 0 | 0 | 0 | 1.3M | 0 | 271K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.79M | -820K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.94M | -22K | 55K | 99K | -100K | -404K | -672K | -955K | -1.16M | 2.58M | 453K | 1.46M | -673K | 179K | 1.38M | 1.09M | 1.63M | 18K | 502K | 58K |
| Working Capital Changes | -426K | 1.56M | 1.96M | 2.03M | 423K | -942K | 3.38M | 1.73M | -6.8M | 2.03M | 808K | 1.89M | -514K | -3.77M | 3.46M | 1.46M | -4.25M | -2M | -572K | 1.83M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.02M | -430K | 602K | -720K | -298K | 310K | 689K | -540K | 23K | 457K | 885K | -501K | -1.88M | 1.02M | 837K | -759K | -756K | 163K | -721K | 912K |
| Cash from Investing | 54.9M | 29.82M | -44.02M | 19.98M | 29.81M | 29.7M | 9.89M | 19.84M | 9.4M | -90.12M | 21.63M | 21.41M | -66.88M | -16.88M | 17.95M | -43.44M | -25.5M | -819K | -573K | -662K |
| Capital Expenditures | -102K | -176K | -45K | -39K | -187K | -299K | -341K | -525K | -88K | -317K | -90K | -193K | -109K | -358K | -63K | -74K | -599K | -819K | -573K | -662K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -89.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 300K | 2.77M | 4.36M | 69.93M | 96K | 543K | 716K | 83K | 253K | 92.98M | 1.63M | 2.48M | 201K | 95.2M | 104K | 309K | 17K | 80.14M | -1.12M | -256K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 300K | 2.77M | 3.29M | 69.93M | 96K | 543K | 716K | 83K | 253K | 92.98M | 1.35M | 2.48M | 0 | 86.65M | 104K | 309K | 17K | 80.16M | -1.12M | -5K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 274K | 0 | 201K | 8.55M | 0 | 0 | 0 | -15K | 0 | -251K |
| Net Change in Cash | 25.28M | 11.96M | -59.81M | 69.14M | 6.53M | 6.29M | -4.67M | 3.8M | -14.8M | -14.52M | 7.85M | 9.24M | -83.09M | 60.31M | 7.42M | -54.53M | -40.68M | 67.24M | -10.38M | -7.42M |
| Free Cash Flow | -30M | -20.64M | -20.19M | -20.81M | -23.54M | -24.25M | -15.61M | -16.65M | -24.54M | -17.7M | -15.49M | -14.84M | -16.52M | -18.37M | -10.82M | -10.7M | -15.8M | -12.9M | -9.26M | -7.16M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -27.41% | 14.87% | -29.3% | -24.98% | 4.07% | -36.98% | -0.78% | -12.23% | -48.54% | 3.63% | -43.15% | -38.65% | -4.57% | -42.36% | -16.84% | -49.49% | -203.36% | -231.83% | - | - |
| FCF per Share | -0.44 | -0.34 | -0.31 | -0.36 | -0.47 | -0.49 | -0.31 | -0.34 | -0.50 | -0.40 | -0.41 | -0.39 | -0.44 | -0.58 | -0.37 | -0.37 | -0.54 | -0.46 | -0.33 | -0.37 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.80x | 0.77x | 0.77x | 0.85x | 0.93x | 0.73x | 0.79x | 1.24x | 0.79x | 0.83x | 0.80x | 0.94x | 1.09x | 0.68x | 0.79x | 1.18x | 1.04x | 0.98x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |